NISHIMURA TAKI

ニシムラタキ | NISHIMURA TAKI

Affiliation and department：
Job title： Professor

Research field (3)： Morphology, anatomy , Chemical biology , Cell biology

Research keywords (3)：膜システム生物学 , タンパク質工学 , Autophagy

Research theme for competitive and other funds (11)：

Show all

Papers (28)：

Wenxin Zhang, Taki Nishimura, Sharon A Tooze. Real-Time Monitoring of ATG8 Lipidation in vitro Using Fluorescence Spectroscopy. Bio-protocol. 2024. 14. 1. e4917
Taki Nishimura, Gianmarco Lazzeri, Sharon A Tooze, Roberto Covino. ATG3 proteins possess a unique amphipathic α-helix essential for the Atg8/LC3 lipidation reaction. Autophagy. 2024. 20. 1. 212-213
Takahiro Shimizu, Norito Tamura, Taki Nishimura, Chieko Saito, Hayashi Yamamoto, Noboru Mizushima. Comprehensive analysis of autophagic functions of WIPI family proteins and their implications for the pathogenesis of β-propeller associated neurodegeneration. Human Molecular Genetics. 2023
Taki Nishimura, Gianmarco Lazzeri, Noboru Mizushima, Roberto Covino, Sharon A Tooze. Unique amphipathic α helix drives membrane insertion and enzymatic activity of ATG3. Science advances. 2023. 9. 25. eadh1281
Wenxin Zhang, Taki Nishimura, Deepanshi Gahlot, Chieko Saito, Colin Davis, Harold B J Jefferies, Anne Schreiber, Lipi Thukral, Sharon A Tooze. Autophagosome membrane expansion is mediated by the N-terminus and cis-membrane association of human ATG8s. eLife. 2023. 12

ｍore...

MISC (29)：

ｍore...

Patents (1)：

Education (2)：

Work history (11)：

2024/07 - 現在 Osaka University
2024/04 - 現在 Osaka University Institute for Protein Research Professor
2021/04 - 2024/03 東京大学大学院医学系研究科 (水島昇教授) さきがけ専任研究員
2019/04 - 2021/03 The Francis Crick Institute Molecular Cell Biology of Autophagy Laboratory Post-Doc
2016/01 - 2019/03 University College London, MRC-LMCB Chris Stefan Lab Research fellow

Show all

Association Membership(s) (3)：

THE JAPANESE BIOCHEMICAL SOCIETY , 日本生物物理学会 , 日本細胞生物学会

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page